68 related articles for article (PubMed ID: 23382097)
1. Serum fibrinogen alpha C-chain 5.9 kDa fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus.
Sogawa K; Noda K; Umemura H; Seimiya M; Kuga T; Tomonaga T; Nishimura M; Kanai F; Imazeki F; Takizawa H; Yoneda M; Nakajima A; Tsutsumi M; Yokosuka O; Nomura F
Proteomics Clin Appl; 2013 Jun; 7(5-6):424-31. PubMed ID: 23382097
[TBL] [Abstract][Full Text] [Related]
2. Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV.
Attallah AM; Mosa TE; Omran MM; Abo-Zeid MM; El-Dosoky I; Shaker YM
J Immunoassay Immunochem; 2007; 28(2):155-68. PubMed ID: 17424834
[TBL] [Abstract][Full Text] [Related]
3. The measurement of a fibrinogen α C-chain 5.9 kDa fragment (FIC 5.9) using MALDI-TOF MS and a stable isotope-labeled peptide standard dilution.
Sogawa K; Kodera Y; Noda K; Ishizuka Y; Yamada M; Umemura H; Maruyama K; Tomonaga T; Yokosuka O; Nomura F
Clin Chim Acta; 2011 May; 412(11-12):1094-9. PubMed ID: 21354123
[TBL] [Abstract][Full Text] [Related]
4. The HCV serum proteome: a search for fibrosis protein markers.
Cheung KJ; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
J Viral Hepat; 2009 Jun; 16(6):418-29. PubMed ID: 19226329
[TBL] [Abstract][Full Text] [Related]
5. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
[TBL] [Abstract][Full Text] [Related]
6. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
7. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C.
Cheung KJ; Tilleman K; Deforce D; Colle I; Moreno C; Gustot T; Van Vlierberghe H
Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):701-10. PubMed ID: 21623191
[TBL] [Abstract][Full Text] [Related]
9. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C.
Attallah AM; Zahran F; Ismail H; Omran MM; El-Dosoky I; Shiha GE
J Immunoassay Immunochem; 2007; 28(4):331-42. PubMed ID: 17885887
[TBL] [Abstract][Full Text] [Related]
11. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
[TBL] [Abstract][Full Text] [Related]
12. Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
Zvibel I; Halfon P; Fishman S; Penaranda G; Leshno M; Or AB; Halpern Z; Oren R
Liver Int; 2009 Feb; 29(2):208-12. PubMed ID: 18694404
[TBL] [Abstract][Full Text] [Related]
13. Development of a sandwich ELISA for the 5.9-kDa fibrinogen alpha C chain fragment detected by serum proteome analysis.
Noda K; Sogawa K; Kikuchi W; Kiyokawa I; Miura T; Kojima R; Katayama K; Kodera Y; Nomura F
Proteomics Clin Appl; 2011 Apr; 5(3-4):141-6. PubMed ID: 21360827
[TBL] [Abstract][Full Text] [Related]
14. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
[TBL] [Abstract][Full Text] [Related]
15. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
16. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18 in patients with chronic hepatitis C.
Abdel Haleem H; Zayed N; Abdel Hafez H; Fouad A; Akl M; Hassan M; Hammam O; Morsy A; Saleh A; Seyam M; Zakaria Z; Zakaria S
Arab J Gastroenterol; 2013 Jun; 14(2):68-72. PubMed ID: 23820504
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
